標(biāo)題: Titlebook: Management of Cardiac Arrhythmias; Gan-Xin Yan,Peter R. Kowey Book 20112nd edition Springer Science+Business Media, LLC 2011 Arrhythmogene [打印本頁] 作者: Stubborn 時間: 2025-3-21 19:02
書目名稱Management of Cardiac Arrhythmias影響因子(影響力)
書目名稱Management of Cardiac Arrhythmias影響因子(影響力)學(xué)科排名
書目名稱Management of Cardiac Arrhythmias網(wǎng)絡(luò)公開度
書目名稱Management of Cardiac Arrhythmias網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Management of Cardiac Arrhythmias被引頻次
書目名稱Management of Cardiac Arrhythmias被引頻次學(xué)科排名
書目名稱Management of Cardiac Arrhythmias年度引用
書目名稱Management of Cardiac Arrhythmias年度引用學(xué)科排名
書目名稱Management of Cardiac Arrhythmias讀者反饋
書目名稱Management of Cardiac Arrhythmias讀者反饋學(xué)科排名
作者: 遺傳學(xué) 時間: 2025-3-21 20:54
Ionic and Cellular Basis for Arrhythmogenesisfor cardiac arrhythmias are divided into two major categories: (1) enhanced or abnormal impulse formation and (2) reentry, which occurs when a propagating impulse fails to die out after normal activation of the heart and persists to re-excite the heart after expiration of the refractory period.作者: condescend 時間: 2025-3-22 03:23
Diagnosis of Arrhythmias with Non-invasive Toolsl therapy can be better ascertained. We provide a comprehensive, yet, concise overview of non-invasive tools to address practical, important, and contemporaneous issues with a focus on patient management. We emphasize strategies to approach challenging clinical scenarios and address how monitoring adds value in specific clinical situations.作者: 喃喃訴苦 時間: 2025-3-22 08:07 作者: cataract 時間: 2025-3-22 08:54 作者: Endemic 時間: 2025-3-22 16:34 作者: 可商量 時間: 2025-3-22 18:28 作者: Modify 時間: 2025-3-22 23:53 作者: Carbon-Monoxide 時間: 2025-3-23 05:25 作者: APNEA 時間: 2025-3-23 08:29
Nonsustained Ventricular Tachycardiastic implications, the role of electrophysiologic study and other risk stratification strategies, and the potential role of pharmacologic and defibrillator intervention depend on the underlying cardiac substrate present in the individual patient. Currently available data regarding the entity are discussed in this chapter.作者: CLEFT 時間: 2025-3-23 11:36 作者: Armory 時間: 2025-3-23 14:44
History of Supraventricular TachycardiaV reentry, atrial flutter (AFL), and atrial fibrillation (AF). We will focus on the historical evolution of the electrophysiologic study of the mechanism and the development of surgical and catheter ablation of these SVTs. We will also discuss potentially newer therapeutic approaches for these arrhy作者: MAIM 時間: 2025-3-23 21:52 作者: 厚臉皮 時間: 2025-3-23 23:01 作者: 圖表證明 時間: 2025-3-24 04:11 作者: 有法律效應(yīng) 時間: 2025-3-24 08:22 作者: 玷污 時間: 2025-3-24 14:05 作者: Introvert 時間: 2025-3-24 16:07
Pharmacologic Management of Atrial Fibrillation and Flutterife, an increased risk for mortality, a significant likelihood of hospitalization, an increased risk for stroke and systemic embolism, and significant costs. Both rate control and rhythm control have been shown to improve quality of life. Neither as a strategy has been proven to reduce mortality ver作者: 四海為家的人 時間: 2025-3-24 22:58
Catheter Ablation of Atrial Flutter and Atrial Fibrillationor catheter ablation. While they are historically grouped together, research over the past 20 years has shown that atrial flutter and atrial fibrillation are distinct arrhythmias with different electrophysiological mechanisms. This review will consider the development of and current approach to cath作者: fructose 時間: 2025-3-24 23:40
Nonsustained Ventricular Tachycardiaf symptoms. More commonly, nonsustained ventricular tachycardia is asymptomatic and the clinician must determine the prognostic importance. The prognostic implications, the role of electrophysiologic study and other risk stratification strategies, and the potential role of pharmacologic and defibril作者: ensemble 時間: 2025-3-25 04:11 作者: Inflated 時間: 2025-3-25 10:25
Indications for Implantable Cardioverter-Defibrillatorssible mechanisms of out-of-hospital cardiac arrest and sudden cardiac death (SCD). Defibrillation is the only predictably effective therapy for reverting VF and pulseless VT to an effective rhythm for restoration of blood flow. Current indications for implantation of implantable cardioverter-defibri作者: 他很靈活 時間: 2025-3-25 15:11 作者: assent 時間: 2025-3-25 17:15 作者: Conquest 時間: 2025-3-25 21:34
Ventricular Tachycardia and Fibrillation: Pharmacologic TherapyThis chapter reviews the clinical pharmacology, electrophysiology, efficacy and safety, and current recommendations of use of class IA, IB, IC, II, and III antiarrhythmic agents in the acute and chronic treatment of ventricular tachycardia. In addition, the role of these drugs in patients with implantable cardioverter-defibrillators is discussed.作者: mitten 時間: 2025-3-26 03:28
https://doi.org/10.1007/978-1-60761-161-5Arrhythmogenesis; Atrial Fibrillation; Catheter Ablation; Electrophysiological; Flutter; J Wave Syndromes作者: 殺死 時間: 2025-3-26 07:25
History of Supraventricular TachycardiaV reentry, atrial flutter (AFL), and atrial fibrillation (AF). We will focus on the historical evolution of the electrophysiologic study of the mechanism and the development of surgical and catheter ablation of these SVTs. We will also discuss potentially newer therapeutic approaches for these arrhythmias.作者: 座右銘 時間: 2025-3-26 09:47
Electrophysiology Study: Indications and Interpretationsctrophysiology study. Indications for an electrophysiology study are then discussed. They include (1) evaluation of syncope, (2) diagnosis of an arrhythmia, (3) evaluation of patients with Wolff–Parkinson–White, and (4) risk stratification of sudden cardiac death. The role of EP studies in non-ischemic cardiomyopathies is also addressed.作者: saturated-fat 時間: 2025-3-26 14:18
Gan-Xin Yan,Peter R. KoweyFeatures new and completely updated chapters, building upon the acclaimed first edition..Describes the latest technical innovations in treatment and insights from current clinical trials..Provides a u作者: Pudendal-Nerve 時間: 2025-3-26 18:48
Contemporary Cardiologyhttp://image.papertrans.cn/m/image/622454.jpg作者: 有惡意 時間: 2025-3-26 22:59
Springer Science+Business Media, LLC 2011作者: 退出可食用 時間: 2025-3-27 01:28
Management of Cardiac Arrhythmias978-1-60761-161-5Series ISSN 2196-8969 Series E-ISSN 2196-8977 作者: 投票 時間: 2025-3-27 05:19 作者: 絕種 時間: 2025-3-27 09:48 作者: Occipital-Lobe 時間: 2025-3-27 17:25
Renee M. Sullivan MD,Wei Wei Li MD,Arthur C. Kendig MD,Brian Olshansky M.D作者: deactivate 時間: 2025-3-27 21:14 作者: 礦石 時間: 2025-3-27 23:16 作者: 伙伴 時間: 2025-3-28 03:44
Ernest Matthew Quin MD,J. Marcus Wharton MD,Michael R. Gold MD, PHD作者: 休戰(zhàn) 時間: 2025-3-28 08:05 作者: expunge 時間: 2025-3-28 11:27
Pharmacologic Management of Atrial Fibrillation and Flutterl strategy must be individualized based on patient characteristics. This chapter will review the considerations necessary for choosing appropriate pharmacologic therapies as well as the therapeutic agents themselves.作者: 先兆 時間: 2025-3-28 14:49 作者: Altitude 時間: 2025-3-28 20:12
Book 20112nd editionlinical trials of and current guidelines for permanent pacemakers and implantable cardioverter-defibrillators.Subsequent chapters focus on arrhythmias in specific populations, including athletes, children, and women during pregnancy.Syndromes such as syncope, long and short QT syndrome, and J wave s作者: 硬化 時間: 2025-3-29 01:01 作者: Mercurial 時間: 2025-3-29 06:43
8樓作者: calorie 時間: 2025-3-29 10:53
8樓作者: 設(shè)施 時間: 2025-3-29 12:46
9樓作者: 別名 時間: 2025-3-29 16:42
9樓作者: LATE 時間: 2025-3-29 23:26
9樓作者: Presbycusis 時間: 2025-3-30 03:08
9樓作者: diathermy 時間: 2025-3-30 07:58
10樓作者: 北京人起源 時間: 2025-3-30 09:25
10樓作者: 剝皮 時間: 2025-3-30 14:50
10樓作者: Cougar 時間: 2025-3-30 19:25
10樓
